EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A Multimodal Nomogram Predicting the Risk of Cognitive Impairment in Parkinson Disease

Ahmed Negida iD

Movement Disorders Clinical Practice · 02.11.2026

DOI: 10.1002/mdc3.70884 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, online erschienen am 02.11.2026. Verfasst von Ahmed Negida. Beteiligte Einrichtung: Parkinson and Movement Disorder Center, Department of Neurology, Virginia Commonwealth University, Richmond, Virginia, USA. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cognitive impairment is the most consequential non‐motor complication of Parkinson's disease (PD), yet no validated tool integrates multimodal data to predict individualized risk trajectories.

Objectives

The aim is to develop and internally validate a time‐to‐event nomogram for predicting 5‐year risk of cognitive impairment in PD using the Parkinson's Precision Markers Initiative (PPMI).

Methods

We analyzed 1188 PD patients with normal cognition at their first cognitive assessment and up to 13 years of follow‐up. Twenty‐seven candidate predictors across seven domains were evaluated. Least absolute shrinkage and selection operator (LASSO)‐penalized Cox regression performed variable selection. Performance was assessed via nested cross‐validation, bootstrap optimism correction, calibration, and time‐dependent area under the curve (AUC).

Results

During median follow‐up of 3.0 years (interquartile range [IQR], 2.0–5.0), 457 patients (38.5%) developed cognitive impairment. LASSO selected 14 predictors. The Cox model achieved a concordance index (C‐index) of 0.747 (optimism‐corrected: 0.733; nested CV: 0.736 ± 0.042), with apparent time‐dependent AUC of 0.77, 0.79, and 0.83 at 3, 5, and 8 years (held‐out: 0.75, 0.78, and 0.81). A companion model without genetic predictors, for unknown GBA status, performed similarly (optimism‐corrected C‐index, 0.729). The strongest predictors were age (hazard ratio [HR], 1.05/year; P < 0.001), GBA mutation (HR, 2.05; P < 0.001), cognitive complaints (HR, 1.67; P < 0.001), and Symbol Digit Modalities Test (HR, 0.98/point; P = 0.001).

Conclusions

A multimodal nomogram integrating clinical, cognitive, genetic, and neuropsychiatric predictors provides individualized estimates of 5‐year risk of cognitive impairment in PD; after external validation, it may support prognostic counseling and trial enrichment.

Schlagwörter

Stichwörter der Autor:innen

Parkinson's diseasecognitive impairmentnomogramprediction modelsurvival analysis

Autor:innen und Institutionen

  • Parkinson and Movement Disorder Center, Department of Neurology, Virginia Commonwealth University, Richmond, Virginia, USA.

ORCID-Profile: Ahmed Negida

Förderung

  • NINDS NIH HHS
  • NIA NIH HHS

Zitieren

APA

Negida, A. (2026). A Multimodal Nomogram Predicting the Risk of Cognitive Impairment in Parkinson Disease. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70884

Vancouver

Negida A. A Multimodal Nomogram Predicting the Risk of Cognitive Impairment in Parkinson Disease. Movement Disorders Clinical Practice. 2026. doi:10.1002/mdc3.70884

BibTeX
@article{Negida2026,
  author = {Negida, Ahmed},
  title = {A Multimodal Nomogram Predicting the Risk of Cognitive Impairment in Parkinson Disease},
  journal = {Movement Disorders Clinical Practice},
  year = {2026},
  doi = {10.1002/mdc3.70884}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche